{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:32:25Z","timestamp":1791124345069,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.tox.2008.03.012","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T16:24:05Z","timestamp":1206635045000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review"],"prefix":"10.1016","volume":"248","author":[{"given":"Jean-Marc","family":"Id\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lancelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Fayoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Corot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2008.03.012_bib1","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","article-title":"Peripheral blood fibrocytes: differentiation pathway and migration to wound sites","volume":"166","author":"Abe","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2008.03.012_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2133.2007.08335.x","article-title":"Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis","volume":"158","author":"Abraham","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1527-3466.2001.tb00182.x","article-title":"Basic experimental studies and clinical aspects of gadolinium salts and chelates","volume":"19","author":"Adding","year":"2001","journal-title":"Cardiovasc. Drugs Rev."},{"key":"10.1016\/j.tox.2008.03.012_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.ki.5002503","article-title":"Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate","volume":"72","author":"Aime","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2008.03.012_bib5","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00330-003-1912-x","article-title":"Currently used non-specific extracellular MR contrast media","volume":"13","author":"Bellin","year":"2003","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0020-1693(99)00106-1","article-title":"Interaction of ATP with a Gd3+ complex employed as paramagnetic contrast agent in NMR imaging","volume":"288","author":"Bianchi","year":"1999","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.tox.2008.03.012_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10334-007-0071-5","article-title":"Imaging in the time of NFD\/NSF: do we have to change our routines concerning renal insufficiency?","volume":"20","author":"Bongartz","year":"2007","journal-title":"Magma"},{"key":"10.1016\/j.tox.2008.03.012_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","article-title":"Gadolinium deposition in nephrogenic fibrosing dermopathy","volume":"56","author":"Boyd","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib9","doi-asserted-by":"crossref","first-page":"W585","DOI":"10.2214\/AJR.07.0191","article-title":"Response to \u201cGadodiamide-associated nephrogenic systemic fibrosis\u201d","volume":"188","author":"Broome","year":"2007","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.tox.2008.03.012_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2214\/AJR.06.1094","article-title":"Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned","volume":"188","author":"Broome","year":"2007","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.tox.2008.03.012_bib11","article-title":"Kinetic stability of gadolinium (III) chelates used as MRI contrast agents","volume":"vol. 221","author":"Br\u00fccher","year":"2002"},{"key":"10.1016\/j.tox.2008.03.012_bib12","series-title":"The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging","first-page":"243","article-title":"Stability and toxicity of contrast agents","author":"Br\u00fccher","year":"2001"},{"key":"10.1016\/j.tox.2008.03.012_bib13","series-title":"Fibrocytes. New Insights into Tissue repair and Systemic Fibrosis","first-page":"1","article-title":"Fibrocytes: discovery of a circulating connective tissue cell progenitor","author":"Bucala","year":"2007"},{"key":"10.1016\/j.tox.2008.03.012_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med."},{"key":"10.1016\/j.tox.2008.03.012_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0730-725X(90)90055-7","article-title":"The relationship between thermodynamics and the toxicity of gadolinium complexes","volume":"8","author":"Cacheris","year":"1990","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib16","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.94.12.6307","article-title":"The peripheral blood fibrocytes is a potent antigen-presenting cell capable of priming naive T cells in situ","volume":"94","author":"Chesney","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2008.03.012_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2451070353","article-title":"Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort","volume":"245","author":"Collidge","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.tox.2008.03.012_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jmri.1880080328","article-title":"Structure\u2013activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme","volume":"8","author":"Corot","year":"1998","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","article-title":"Nephrogenic fibrosing dermopathy: the first 6 years","volume":"15","author":"Cowper","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.tox.2008.03.012_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yadr.2007.07.002","article-title":"Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium","volume":"23","author":"Cowper","year":"2007","journal-title":"Adv. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11926-006-0056-9","article-title":"Nephrogenic systemic fibrosis: an update","volume":"8","author":"Cowper","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.tox.2008.03.012_bib22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2008.03.012_bib23","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/sj.ejcn.1601479","article-title":"Zinc and immune function","volume":"56","author":"Dardenne","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.tox.2008.03.012_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1525-139X.2007.00416.x","article-title":"Can the risk of gadolinium be extrapolated to lanthanum?","volume":"21","author":"De Broe","year":"2008","journal-title":"Semin. Dial."},{"key":"10.1016\/j.tox.2008.03.012_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1021\/ic50207a042","article-title":"Nuclear magnetic resonance spectroscopy of lanthanide complexes with a tetraacetic-tetraaza macrocycle. Unusual conformation properties","volume":"19","author":"Desreux","year":"1980","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.tox.2008.03.012_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/RLI.0b013e318137a471","article-title":"Preclinical safety evaluation of Gd-EOB-DTPA (Primovist)","volume":"42","author":"D\u00f6hr","year":"2007","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2006.07652.x","article-title":"Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum","volume":"156","author":"Edward","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/path.2311","article-title":"Gadodiamide contrast agent \u2018activates\u2019 fibroblasts: a possible cause of nephrogenic systemic fibrosis","volume":"214","author":"Edward","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.tox.2008.03.012_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/gfg506","article-title":"Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tox.2008.03.012_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1634\/stemcells.22-5-812","article-title":"Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair","volume":"22","author":"Fathke","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.tox.2008.03.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp. Biol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.tox.2008.03.012_bib32","first-page":"162","article-title":"Stability of gadolinium-based contrast agents in human serum","volume":"18","author":"Frenzel","year":"2008","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.bor.0000245725.94887.8d","article-title":"Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)","volume":"18","author":"Galan","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.tox.2008.03.012_bib34","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jaad.2006.04.061","article-title":"Nephrogenic fibrosing dermopathy with recurrence after allograft failure","volume":"56","author":"Goddard","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaad.2007.07.010","article-title":"Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis","volume":"57","author":"Goveia","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20021234","article-title":"Transglutaminases: nature's biological glues","volume":"368","author":"Griffin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.tox.2008.03.012_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. 1","key":"10.1016\/j.tox.2008.03.012_bib38","first-page":"29","article-title":"Toxicology of contrast media for magnetic resonance imaging. A brief review","volume":"1","author":"G\u00fcnzel","year":"1992","journal-title":"Adv. MRI Contrast"},{"key":"10.1016\/j.tox.2008.03.012_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)63459-1","article-title":"A novel role for erythropoietin during fibrin-induced wound-healing response","volume":"163","author":"Haroon","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2008.03.012_bib40","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/00004424-199303001-00004","article-title":"Preclinical safety assessment and phamacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent","volume":"28","author":"Harpur","year":"1993","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0730-725X(93)90194-I","article-title":"Hepato-biliary and renal excretion in mice of charged and neutral gadolinium complexes of cyclic tetra-aza-phosphinic and carboxylic acids","volume":"11","author":"Harrison","year":"1993","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaad.2007.01.022","article-title":"Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcpa.2005.01.011","article-title":"Effects of gadolinium chloride (GdCl3) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions","volume":"133","author":"Ide","year":"2005","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.tox.2008.03.012_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1472-8206.2006.00447.x","article-title":"Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review","volume":"20","author":"Id\u00e9e","year":"2006","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2008.03.012_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/oxfordjournals.jbchem.a134655","article-title":"Characterization of Gd3+ and Tb3+ binding sites on Ca2+ Mg2+ \u2013 adenosine triphosphatase of sarcoplasmic reticulum","volume":"95","author":"Itoh","year":"1984","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.tox.2008.03.012_bib47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00467-003-1380-1","article-title":"Nephrogenic fibrosing dermopathy in pediatric patients","volume":"19","author":"Jain","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.tox.2008.03.012_bib48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/AJR.06.1616","article-title":"ACR guidance document for safe MR practices: 2007","volume":"188","author":"Kanal","year":"2007","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.tox.2008.03.012_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiol.2461071267","article-title":"Response to the FDA's May 23 2007, nephrogenic systemic fibrosis update","volume":"246","author":"Kanal","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.tox.2008.03.012_bib51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00007890-199704150-00026","article-title":"In vivo hyperexpression of transforming growth-factor-beta 1 in mice: stimulation by cyclosporine","volume":"63","author":"Khanna","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.tox.2008.03.012_bib52","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2741\/2030","article-title":"Transglutaminase 2 in inflammation","volume":"11","author":"Kim","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.tox.2008.03.012_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-8388(96)02644-8","article-title":"Macrocyclic polyamino carboxylate complexes of Gd (III) as magnetic resonance imaging contrast agents","volume":"249","author":"Kumar","year":"1997","journal-title":"J. Alloys Comp."},{"key":"10.1016\/j.tox.2008.03.012_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/ic00057a017","article-title":"Equilibrium and kinetic studies of lanthanide complexes of macrocyclic polyamino carboxylates","volume":"32","author":"Kumar","year":"1993","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.tox.2008.03.012_bib55","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1021\/ic00130a012","article-title":"Synthesis, stability, and crystal structure studies of some Ca2+, Cu2+, and Zn2+ complexes of macrocyclic polyamino carboxylates","volume":"34","author":"Kumar","year":"1995","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.tox.2008.03.012_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiol.2423061640","article-title":"Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis","volume":"242","author":"Kuo","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.tox.2008.03.012_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1139\/y03-012","article-title":"Endothelin-1 in chronic renal failure and hypertension","volume":"81","author":"Larivi\u00e8re","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tox.2008.03.012_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004424-200102000-00008","article-title":"Stability of MRI paramagnetic contrast media. A proton relaxometric protocol for transmetallation assessment","volume":"36","author":"Laurent","year":"2001","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cmmi.100","article-title":"Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents","volume":"1","author":"Laurent","year":"2006","journal-title":"Contrast Med. Mol. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib60","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2008.03.012_bib61","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/ndt\/gfm261","article-title":"Case\u2013control study of gadodiamide-related nephrogenic systemic fibrosis","volume":"22","author":"Marckmann","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tox.2008.03.012_bib62","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ki.5000368","article-title":"Contrast-induced nephropathy: definition, epidimiology, and patients at risk","volume":"69","author":"Mehran","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2008.03.012_bib63","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","article-title":"Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature","volume":"35","author":"Mendoza","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.tox.2008.03.012_bib64","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1097\/00004424-198809001-00048","article-title":"Gd-DOTA, a potential MRI contrast agent, Current status of physicochemical knowledge","volume":"23","author":"Meyer","year":"1988","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1259\/bjr\/17111243","article-title":"Nephrogenic systemic fibrosis following the administration of extracellular gadolinium-based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?","volume":"80","author":"Morcos","year":"2007","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib66","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1002\/chem.200400006","volume":"10","author":"Moreau","year":"2004","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.tox.2008.03.012_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1744-9987.2007.00432.x","article-title":"Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage","volume":"11","author":"Oka","year":"2007","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.tox.2008.03.012_bib68","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/ndt\/gfm584","article-title":"Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure","volume":"22","author":"Othersen","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tox.2008.03.012_bib69","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.18388\/abp.2000_3963","article-title":"Toxicological and cytophysiological aspects of lanthanides action","volume":"47","author":"Palasz","year":"2000","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.tox.2008.03.012_bib70","first-page":"69","article-title":"Zinc and copper concentrations in plasma and erythrocytes of patients of chronic renal failure","volume":"12","author":"Paniagua-Sierra","year":"1981","journal-title":"Arch. Invest. Med. (Mex.)"},{"key":"10.1016\/j.tox.2008.03.012_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/DAD.0b013e318156e43f","article-title":"Transglutaminases: the missing link in nephrogenic systemic fibrosis","volume":"29","author":"Parsons","year":"2007","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.tox.2008.03.012_bib72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2215\/CJN.00030107","article-title":"Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?","volume":"2","author":"Perazella","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2008.03.012_bib73","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2008.03.012_bib74","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.171.10.5537","article-title":"Inhibition of fibrocytes differentiation by serum amyloid P","volume":"171","author":"Pilling","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2008.03.012_bib75","doi-asserted-by":"crossref","first-page":"181102","DOI":"10.1063\/1.2736369","article-title":"Ab initio simulation of a gadolinium-based magnetic resonance imaging contrast agent in aqueous solution","volume":"126","author":"Pollet","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.tox.2008.03.012_bib76","unstructured":"Port, M., Id\u00e9e, J.M., Medina, C., Robic, C., Sabatou, M., Corot, C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals, in press."},{"key":"10.1016\/j.tox.2008.03.012_bib77","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.nu.05.070185.002013","article-title":"Clinical manifestations of zinc deficiency","volume":"5","author":"Prasad","year":"1985","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.tox.2008.03.012_bib78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1525-139X.2006.00172.x","article-title":"Erythropoietin resistance in the treatment of the anemia of chronic renal failure","volume":"19","author":"Priyadarshi","year":"2006","journal-title":"Sem. Dial."},{"key":"10.1016\/j.tox.2008.03.012_bib79","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1039\/p29930000605","article-title":"Synthesis of charged and uncharged complexes of gadolinium and yttrium with cyclic polyazaphosphinic acid ligands for in vivo applications","volume":"2","author":"Pulukkody","year":"1993","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.tox.2008.03.012_bib80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004424-199612000-00001","article-title":"Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents","volume":"31","author":"Puttagunta","year":"1996","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/RLI.0b013e31815a3407","article-title":"High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent","volume":"43","author":"Rydahl","year":"2008","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib82","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2007.10.012","article-title":"Epoietin and nephrogenic systemic fibrosis","volume":"58","author":"Saab","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2008.03.012_bib83","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1542-4758.2007.00222.x","article-title":"Nephrogenic systemic fibrosis: a nephrologist's perspective","volume":"11","author":"Saab","year":"2007","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.tox.2008.03.012_bib84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","article-title":"Nephrogenic systemic fibrosis: risk factors and incidence estimation","volume":"243","author":"Sadowski","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.tox.2008.03.012_bib85","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s002239900567","article-title":"Fluid shear stress increases transforming growth factor beta-1 expression in human osteoblast-like cells: modulation by cation channel blockade","volume":"63","author":"Sakai","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tox.2008.03.012_bib86","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/(SICI)1521-3765(20000218)6:4<719::AID-CHEM719>3.0.CO;2-2","article-title":"The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging","volume":"6","author":"Sarka","year":"2000","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.tox.2008.03.012_bib87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.forsciint.2007.06.026","article-title":"Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis","volume":"176","author":"Saussereau","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.tox.2008.03.012_bib88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E","article-title":"Safety of magnetic resonance imaging contrast agents","volume":"10","author":"Shellock","year":"1999","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.102.047092","article-title":"l-homocysteine sulfinic acid and other acidic homocystein homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists","volume":"305","author":"Shi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2008.03.012_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/RLI.0b013e31815e6277","article-title":"A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media","volume":"43","author":"Sieber","year":"2008","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/bchm3.1988.369.1.275","article-title":"Human erythrocyte transglutaminase: purification and preliminary characterization","volume":"369","author":"Signorini","year":"1988","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.tox.2008.03.012_bib92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/019262339702500301","article-title":"Gadolinium chloride toxicity in the rat","volume":"25","author":"Spencer","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2008.03.012_bib93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.rli.0000208223.34203.49","article-title":"Preclinical safety assessment of Vasovist (gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography","volume":"41","author":"Steger-Hartmann","year":"2006","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib94","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2007060645","article-title":"New insights into nephrogenic systemic fibrosis","volume":"18","author":"Swaminathan","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2008.03.012_bib95","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-145-3-200608010-00021","article-title":"Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy","volume":"145","author":"Swaminathan","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tox.2008.03.012_bib96","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMc070248","article-title":"Nephrogenic systemic fibrosis, gadolinium, and iron mobilization","volume":"357","author":"Swaminathan","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tox.2008.03.012_bib97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jn\/95.1.8","article-title":"Severe zinc deficiency in male and female rats","volume":"95","author":"Swernerton","year":"1968","journal-title":"J. Nutr."},{"key":"10.1016\/j.tox.2008.03.012_bib98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cmmi.146","article-title":"Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications","volume":"2","author":"Thakral","year":"2007","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib99","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s00330-006-0495-8","article-title":"Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide","volume":"16","author":"Thomsen","year":"2006","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib100","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1021\/ic00096a036","article-title":"Kinetics of formation and dissociation of lanthanide(III)-DOTA complexes","volume":"33","author":"T\u00f3th","year":"1994","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.tox.2008.03.012_bib101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0020-1693(96)05094-3","article-title":"Equilibrium and kinetic studies on complexes of 10-[2,3-dihydroxy-(1-hydroxymethyl)-propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate","volume":"249","author":"T\u00f3th","year":"1996","journal-title":"Inorg. Acta"},{"key":"10.1016\/j.tox.2008.03.012_bib102","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00004424-199208001-00002","article-title":"Physicochemical properties of gadoteridol and other magnetic resonance contrast agents","volume":"27","author":"Tweedle","year":"1992","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0730-725X(91)90429-P","article-title":"Reaction of gadolinium chelates with endogenously available ions","volume":"9","author":"Tweedle","year":"1991","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib104","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004424-199506000-00008","article-title":"Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate and gadodiamide in mice and rats","volume":"30","author":"Tweedle","year":"1995","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/ic00107a017","volume":"34","author":"Uggeri","year":"1995","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.tox.2008.03.012_bib106","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","article-title":"Transforming growth factor-\u03b2 and fibrosis","volume":"13","author":"Verrechia","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2008.03.012_bib107","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0730-725X(92)90016-S","article-title":"Dissociation of gadolinium chelates in mice: relationship to chemical characteristics","volume":"10","author":"Wedeking","year":"1992","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.tox.2008.03.012_bib108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","article-title":"Comparison of Gd-(DTPA-BMA) (Omniscan) versus Gd-(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy","volume":"41","author":"White","year":"2006","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib109","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004424-200107000-00006","article-title":"Toxicological assessment of gadoversetamide injection (OptiMARK), a new contrast-enhancement agent for use in magnetic resonance imaging","volume":"36","author":"Wible","year":"2001","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.tox.2008.03.012_bib110","first-page":"1","article-title":"Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue","volume":"190","author":"Wiginton","year":"2008","journal-title":"AJR"},{"key":"10.1016\/j.tox.2008.03.012_bib111","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.03250906","article-title":"Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure. Role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate","volume":"2","author":"Yerram","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X08001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X08001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:01:20Z","timestamp":1759532480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X08001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":111,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0300483X08001431"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2008.03.012","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2008.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}